At a glance
- Originator Pharmacia Corporation
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Seizures
Most Recent Events
- 06 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 07 Sep 1998 New profile
- 07 Sep 1998 Preclinical development for Seizures in Italy (Unknown route)